Logo image of CAH

CARDINAL HEALTH INC (CAH) Stock Price, Quote, News and Overview

NYSE:CAH - New York Stock Exchange, Inc. - US14149Y1082 - Common Stock - Currency: USD

123.66  -4.6 (-3.59%)

After market: 123.66 0 (0%)

CAH Quote, Performance and Key Statistics

CARDINAL HEALTH INC

NYSE:CAH (1/31/2025, 8:15:29 PM)

After market: 123.66 0 (0%)

123.66

-4.6 (-3.59%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Distributors
Statistics
52 Week High132.84
52 Week Low93.17
Market Cap29.93B
Shares242.01M
Float241.37M
Yearly Dividend2.02
Dividend Yield1.55%
PE16
Fwd PE14.01
Earnings (Next)N/A N/A
IPO08-04 1983-08-04


CAH short term performance overview.The bars show the price performance of CAH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20

CAH long term performance overview.The bars show the price performance of CAH in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of CAH is 123.66 USD. In the past month the price increased by 4.56%. In the past year, price increased by 19.52%.

CARDINAL HEALTH INC / CAH Daily stock chart

CAH Latest News, Press Releases and Analysis

News Image
7 hours ago - Yahoo Finance

Cardinal Health (NYSE:CAH) Beats Q4 Sales Targets

Healthcare distributor and services company Cardinal Health (NYSE:CAH) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3.8% year on year to $55.26 billion. Its non-GAAP profit of $1.93 per share was 9.4% above analysts’ consensus estimates.

News Image
7 hours ago - StockStory

Cardinal Health (NYSE:CAH) Beats Q4 Sales Targets

Healthcare distributor and services company Cardinal Health (NYSE:CAH) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3.8% year on year to $55.26 billion. Its non-GAAP profit of $1.93 per share was 9.4% above analysts’ consensus estimates.

News Image
2 days ago - Cardinal Health, Inc.

Cardinal Health Reports Second Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration GAAP1...

News Image
3 days ago - Benzinga

Marjorie Taylor Greene Loads Up On Meta, Amazon, Tesla, Nvidia And Other Stocks As Donald Trump's New Equations With Big Tech Leaders Sets Stage For Growth: What Is At Stake?

U.S. House Representative Marjorie Taylor Greene has disclosed new trades as Donald Trump's equations evolves with Big Tech leaders.

News Image
18 days ago - Cardinal Health

Cardinal Health to open new distribution center in Fort Worth, Texas

/PRNewswire/ -- Cardinal Health (NYSE: CAH) announced construction is underway on a new distribution center in Fort Worth, Texas, which will support its...

CAH Competitors/Peers

The largest stocks on the US markets in the "Health Care Distributors" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
MCK MCKESSON CORP 20.6 75.50B
COR CENCORA INC 18.47 49.13B
HSIC HENRY SCHEIN INC 19 9.97B
PDCO PATTERSON COS INC 14.6 2.73B
AHCO ADAPTHEALTH CORP N/A 1.46B
OMI OWENS & MINOR INC 8.58 1.10B
AHG AKSO HEALTH GROUP N/A 510.49M
COSM COSMOS HEALTH INC N/A 16.47M
VRAX VIRAX BIOLABS GROUP LTD N/A 7.33M
ATPC AGAPE ATP CORP N/A 5.59M

About CAH

Company Profile

CAH logo image Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 48,900 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

Company Info

CARDINAL HEALTH INC

7000 Cardinal Pl

Dublin Ohio OHIO 43017 US

CEO: Michael C. Kaufmann

Employees: 48411

Company Website: https://www.cardinalhealth.com/en.html

Investor Relations: https://ir.cardinalhealth.com/

Phone: 16147573033

CAH FAQ

What is the stock price of CAH?

The current stock price of CAH is 123.66 USD.


What is the symbol for CARDINAL HEALTH INC stock?

The exchange symbol of CARDINAL HEALTH INC is CAH and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is CAH stock listed?

CAH stock is listed on the New York Stock Exchange, Inc. exchange.


Is CAH a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CAH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CAH.


Does CAH stock pay dividends?

CAH has a dividend yield of 1.55%. The yearly dividend amount is currently 2.02.


What is the Price/Earnings (PE) ratio of CAH?

The PE ratio for CAH is 16. This is based on the reported non-GAAP earnings per share of 7.73 and the current share price of 123.66 USD.


What is the Short Interest ratio of CAH stock?

The outstanding short interest for CAH is 1.75% of its float.


CAH Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to CAH. When comparing the yearly performance of all stocks, CAH is one of the better performing stocks in the market, outperforming 72.85% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CAH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CAH. Both the profitability and the financial health of CAH get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CAH Financial Highlights

Over the last trailing twelve months CAH reported a non-GAAP Earnings per Share(EPS) of 7.73. The EPS increased by 13.01% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.56%
ROA 2.93%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%6.04%
Sales Q2Q%-3.8%
EPS 1Y (TTM)13.01%
Revenue 1Y (TTM)10.64%

CAH Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 75% to CAH. The Buy consensus is the average rating of analysts ratings from 22 analysts.

For the next year, analysts expect an EPS growth of 6.22% and a revenue growth -2.36% for CAH


Ownership
Inst Owners90.49%
Ins Owners0.26%
Short Float %1.75%
Short Ratio1.83
Analysts
Analysts74.55
Price Target138.29 (11.83%)
EPS Next Y6.22%
Revenue Next Year-2.36%